Salmonics was recently spotlighted by NEWS CENTER Maine on WCSH 6 and WLBZ 2. Reporter Vivien Leigh and her team visited our labs at TechPlace in Brunswick to explore how we are turning seafood byproducts into cutting-edge research and diagnostic tools that advance medical technology and help save lives. We are proud to share our…
PORTLAND, ME – September 4, 2025 – Salmonics was featured in Mainebiz’s article, “TechPlace startup to advance biomedical product development through Roux residency” by Laurie Schreiber. According to the article: Salmonics, a biotech startup at TechPlace in Brunswick, is taking part in a 12-month residency at Northeastern University’s Roux Institute in Portland with a goal…
BRUNSWICK & PORTLAND, ME – August 27, 2025 – We’re joining forces to advance fish-derived research tools and clinical solutions in a way that supports science and sustainability. Salmonics contributes expertise in developing high-quality reagents and next-generation biomedical products. SalmoGen, an Atlantic salmon breeding company, has provided access to thriving, biosecure salmon populations at the University of Maine’s…
BRUNSWICK & PORTLAND, ME – July 2, 2025 – Salmonics, a pioneering provider of biomedical products derived from fish proteins, has become an inaugural member of the BioPILOT Lab, a program of Northeastern University’s Roux Institute in Portland, Maine. The company will leverage this opportunity to refine its technology and enhance the development of its…
When I was a child, I once told my mother I wanted to be a researcher when I grew up. At the time, I don’t think either of us realized how much that statement would shape my life. My path has always followed a deep love of nature, especially the ocean. As a teenager growing…
Salmonics is proud to announce the soft launch of our new salmon-derived Fibronectin, available now for early adopter testing with a limited time 10% discount for those who join us in refining this product ahead of its full commercial release this fall. A Product Years in the Making The development of Salmonics’ Fibronectin began with…
Biomedicine is often defined by its scientific breakthroughs, but the impact of the life sciences in Maine reaches far beyond the lab. The industry is a powerful economic driver, shaping communities, creating jobs, and fueling growth across the state. It is an exciting time to be a scientist in Maine, with life science jobs significantly…
Salmonics had an exciting start to the new year thanks to the Society for Laboratory Automation and Screening (SLAS) Conference in January! Hosted at the San Diego Convention Center, our team was able to network with other innovative companies and share our vision for a more sustainable future using our fish-derived biomedical products. As part…
From the Cold War to high tech: Behind the scenes at TechPlace, Brunswick’s business incubator, by Renee Cordes, MaineBiz 10/21/2024 Read the full article online (PDF) TechPlace, an incubator space for manufacturing and technology startups, opened in 2015 as part of the redevelopment of Brunswick Landing, aiming to support small businesses. TechPlace fosters a…
Read the full press release here. BRUNSWICK, MAINE, UNITED STATES, July 18, 2024 /EINPresswire.com/ — Salmonics, Inc. [Salmonics] a leading biotechnology innovator, today announced a strategic investment from Lerøy Seafood Group [Lerøy] a global leader in sustainable seafood production. This investment will support Salmonics’ continued growth and development of cutting-edge biotechnological solutions utilizing fish blood. Lerøy, a Norwegian-based company…